The functional role of microRNAs in alcoholic liver injury

Journal of Cellular and Molecular Medicine

Volumn 18, Issue 2, 2014, Pages 197-207

  Mcdaniel, Kelly ^a,b   Herrera, Leonardo ^c   Zhou, Tianhao ^b   Francis, Heather ^a,b   Han, Yuyan ^a,b   Levine, Phillip ^a,b   Lin, Emily ^c   Glaser, Shannon ^a,b   Alpini, Gianfranco ^a,b   Meng, Fanyin ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^c Undergraduate Research Program   (United States)

Author keywords

Alcoholic liver diseases; Apoptosis; Kupffer cells; LPS; MicroRNAs; TLR4; TNF

Indexed keywords

NEGIBACTERIA;

ALCOHOL; LIPOPOLYSACCHARIDE; MICRORNA; TLR4 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ALCOHOL LIVER DISEASE; ALCOHOLIC LIVER DISEASES; APOPTOSIS; ARTICLE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; INTESTINE; KUPFFER CELL; LIVER; LIVER CELL; METABOLISM; PATHOLOGY; PERMEABILITY; SIGNAL TRANSDUCTION; STELLATE CELL; TNF-Α;

ALCOHOLIC LIVER DISEASES; APOPTOSIS; KUPFFER CELLS; LPS; MICRORNAS; TLR4; TNF-Α;

ETHANOL; GENE EXPRESSION REGULATION; HEPATIC STELLATE CELLS; HEPATOCYTES; HUMANS; INTESTINES; KUPFFER CELLS; LIPOPOLYSACCHARIDES; LIVER; LIVER DISEASES, ALCOHOLIC; MICRORNAS; PERMEABILITY; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84893692701     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12223     Document Type: Article

References (106)

1. Massey VL, Arteel GE. Acute alcohol-induced liver injury. Front Physiol. 2012; 3: 193.
2. Adachi M, Brenner DA. Clinical syndromes of alcoholic liver disease. Dig Dis. 2005; 23: 255-63.
3. Tilg H, Day CP. Management strategies in alcoholic liver disease. Nat Clin Pract Gastroenterol Hepatol. 2007; 4: 24-34.
4. Pompili M, Serafini G, Innamorati M, et al. Suicidal behavior and alcohol abuse. Int J Environ Res Public Health. 2010; 7: 1392-431.
5. Miranda RC, Pietrzykowski AZ, Tang Y, et al. MicroRNAs: master regulators of ethanol abuse and toxicity? Alcohol Clin Exp Res. 2010; 34: 575-87.
6. Bala S, Szabo G. MicroRNA signature in alcoholic liver disease. Int J Hepatol. 2012; 2012: 498232.
7. Thompson KJ, McKillop IH, Schrum LW. Targeting collagen expression in alcoholic liver disease. World J Gastroenterol. 2011; 17: 2473-81.
8. Mello T, Polvani S, Galli A. Peroxisome proliferator-activated receptor and retinoic x receptor in alcoholic liver disease. PPAR Res. 2009; 2009: 748174.
9. Szabo G, Bala S. Alcoholic liver disease and the gut-liver axis. World J Gastroenterol. 2010; 16: 1321-9.
10. Ambros V. The functions of animal microRNAs. Nature. 2004; 431: 350-5.
11. Ambros V. MicroRNAs and developmental timing. Curr Opin Genet Dev. 2011; 21: 511-7.
12. Gao B, Bataller R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology. 2011; 141: 1572-85.
13. Szabo G, Petrasek J, Bala S. Innate immunity and alcoholic liver disease. Dig Dis. 2012; 30: 55-60.
14. Keshavarzian A, Farhadi A, Forsyth CB, et al. Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats. J Hepatol. 2009; 50: 538-47.
15. Mathurin P, Deng QG, Keshavarzian A, et al. Exacerbation of alcoholic liver injury by enteral endotoxin in rats. Hepatology. 2000; 32: 1008-17.
16. Bode C, Kugler V, Bode JC. Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess. J Hepatol. 1987; 4: 8-14.
17. Hellman J, Loiselle PM, Tehan MM, et al. Outer membrane protein A, peptidoglycan-associated lipoprotein, and murein lipoprotein are released by Escherichia coli bacteria into serum. Infect Immun. 2000; 68: 2566-72.
18. Rao RK. Acetaldehyde-induced increase in paracellular permeability in Caco-2 cell monolayer. Alcohol Clin Exp Res. 1998; 22: 1724-30.
19. Wheeler MD, Kono H, Yin M, et al. The role of Kupffer cell oxidant production in early ethanol-induced liver disease. Free Radic Biol Med. 2001; 31: 1544-9.
20. Thakur V, McMullen MR, Pritchard MT, et al. Regulation of macrophage activation in alcoholic liver disease. J Gastroenterol Hepatol. 2007; 22: S53-6.
21. Bode C, Bode JC. Effect of alcohol consumption on the gut. Best Pract Res Clin Gastroenterol. 2003; 17: 575-92.
22. Takeda K, Akira S. TLR signaling pathways. Semin Immunol. 2004; 16: 3-9.
23. da Silva Correia J, Soldau K, Christen U, et al. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. transfer from CD14 to TLR4 and MD-2. J Biol Chem. 2001; 276: 21129-35.
24. Mandrekar P, Szabo G. Signalling pathways in alcohol-induced liver inflammation. J Hepatol. 2009; 50: 1258-66.
25. Hritz I, Mandrekar P, Velayudham A, et al. The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88. Hepatology. 2008; 48: 1224-31.
26. Antal-Szalmas P, Strijp JA, Weersink AJ, et al. Quantitation of surface CD14 on human monocytes and neutrophils. J Leukoc Biol. 1997; 61: 721-8.
27. Liu S, Khemlani LS, Shapiro RA, et al. Expression of CD14 by hepatocytes: upregulation by cytokines during endotoxemia. Infect Immun. 1998; 66: 5089-98.
28. Haziot A, Ferrero E, Kontgen F, et al. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity. 1996; 4: 407-14.
29. Nath B, Szabo G. Alcohol-induced modulation of signaling pathways in liver parenchymal and nonparenchymal cells: implications for immunity. Semin Liver Dis. 2009; 29: 166-77.
30. Guo J, Friedman SL. Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis. Fibrogenesis Tissue Repair. 2010; 3: 21.
31. Bala S, Marcos M, Kodys K, et al. Upregulation of microRNA-155 in macrophages contributes to increased tumor necrosis factor alpha (TNF{alpha}) production via increased mRNA half-life in alcoholic liver disease. J Biol Chem. 2011; 286: 1436-44.
32. Sheedy FJ, Palsson-McDermott E, Hennessy EJ, et al. Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol. 2010; 11: 141-7.
33. Kawai T, Takeuchi O, Fujita T, et al. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J Immunol. 2001; 167: 5887-94.
34. Roychowdhury S, McMullen MR, Pritchard MT, et al. An early complement-dependent and TLR-4-independent phase in the pathogenesis of ethanol-induced liver injury in mice. Hepatology. 2009; 49: 1326-34.
35. Nahid MA, Pauley KM, Satoh M, et al. miR-146a is critical for endotoxin-induced tolerance: IMPLICATION IN INNATE IMMUNITY. J Biol Chem. 2009; 284: 34590-9.
36. Taganov KD, Boldin MP, Chang KJ, et al. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA. 2006; 103: 12481-6.
37. Hill DB, Barve S, Joshi-Barve S, et al. Increased monocyte nuclear factor-kappaB activation and tumor necrosis factor production in alcoholic hepatitis. J Lab Clin Med. 2000; 135: 387-95.
38. Koop DR, Klopfenstein B, Iimuro Y, et al. Gadolinium chloride blocks alcohol-dependent liver toxicity in rats treated chronically with intragastric alcohol despite the induction of CYP2E1. Mol Pharmacol. 1997; 51: 944-50.
39. Thurman RG. II. Alcoholic liver injury involves activation of Kupffer cells by endotoxin. Am J Physiol Gastrointest Liver Physiol. 1998; 275: G605-11.
40. Iimuro Y, Gallucci RM, Luster MI, et al. Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat. Hepatology. 1997; 26: 1530-7.
41. Uesugi T, Froh M, Arteel GE, et al. Role of lipopolysaccharide-binding protein in early alcohol-induced liver injury in mice. J Immunol. 2002; 168: 2963-9.
42. Tili E, Michaille JJ, Cimino A, et al. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol. 2007; 179: 5082-9.
43. Szabo G, Bala S, Petrasek J, et al. Gut-liver axis and sensing microbes. Dig Dis. 2010; 28: 737-44.
44. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993; 75: 843-54.
45. Griffiths-Jones S. The microRNA registry. Nucleic Acids Res. 2004; 32: D109-11.
46. Moss TJ, Wallrath LL. Connections between epigenetic gene silencing and human disease. Mutat Res. 2007; 618: 163-74.
47. Rodenhiser D, Mann M. Epigenetics and human disease: translating basic biology into clinical applications. CMAJ. 2006; 174: 341-8.
48. Bejarano F, Bortolamiol-Becet D, Dai Q, et al. A genome-wide transgenic resource for conditional expression of Drosophila microRNAs. Development. 2012; 139: 2821-31.
49. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009; 136: 215-33.
50. Sinkkonen L, Hugenschmidt T, Berninger P, et al. MicroRNAs control de novo DNA methylation through regulation of transcriptional repressors in mouse embryonic stem cells. Nat Struct Mol Biol. 2008; 15: 259-67.
51. Garzon R, Liu S, Fabbri M, et al. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Blood. 2009; 113: 6411-8.
52. Meng F, Glaser S, Francis H, et al. Epigenetic regulation of miR-34a expression in alcoholic liver injury. Am J Pathol. 2012; 181: 804-17.
53. Kutay H, Klepper C, Wang B, et al. Reduced susceptibility of DNA methyltransferase 1 hypomorphic (Dnmt1N/+) mice to hepatic steatosis upon feeding liquid alcohol diet. PLoS ONE. 2012; 7: e41949.
54. Davison JM, Mellott TJ, Kovacheva VP, et al. Gestational choline supply regulates methylation of histone H3, expression of histone methyltransferases G9a (Kmt1c) and Suv39h1 (Kmt1a), and DNA methylation of their genes in rat fetal liver and brain. J Biol Chem. 2009; 284: 1982-9.
55. Pogribny IP, Tryndyak VP, Bagnyukova TV, et al. Hepatic epigenetic phenotype predetermines individual susceptibility to hepatic steatosis in mice fed a lipogenic methyl-deficient diet. J Hepatol. 2009; 51: 176-86.
56. Oliva J, Dedes J, Li J, et al. Epigenetics of proteasome inhibition in the liver of rats fed ethanol chronically. World J Gastroenterol. 2009; 15: 705-12.
57. Petrak J, Myslivcova D, Man P, et al. Proteomic analysis of hepatic iron overload in mice suggests dysregulation of urea cycle, impairment of fatty acid oxidation, and changes in the methylation cycle. Am J Physiol Gastrointest Liver Physiol. 2007; 292: G1490-8.
58. Shukla SD, Aroor AR. Epigenetic effects of ethanol on liver and gastrointestinal injury. World J Gastroenterol. 2006; 12: 5265-71.
59. Bonsch D, Lenz B, Fiszer R, et al. Lowered DNA methyltransferase (DNMT-3b) mRNA expression is associated with genomic DNA hypermethylation in patients with chronic alcoholism. J Neural Transm. 2006; 113: 1299-304.
60. Bielawski DM, Abel EL. The effect of administering ethanol as single vs. divided doses on blood alcohol levels in the rat. Neurotoxicol Teratol. 2002; 24: 559-62.
61. Bielawski DM, Zaher FM, Svinarich DM, et al. Paternal alcohol exposure affects sperm cytosine methyltransferase messenger RNA levels. Alcohol Clin Exp Res. 2002; 26: 347-51.
62. Ouko LA, Shantikumar K, Knezovich J, et al. Effect of alcohol consumption on CpG methylation in the differentially methylated regions of H19 and IG-DMR in male gametes: implications for fetal alcohol spectrum disorders. Alcohol Clin Exp Res. 2009; 33: 1615-27.
63. El-Moselhy MA, Abdel-Hamid NM, Abdel-Raheim SR. Gastroprotective effect of nicorandil in indomethacin and alcohol-induced acute ulcers. Appl Biochem Biotechnol. 2009; 152: 449-59.
64. Shukla SD, Velazquez J, French SW, et al. Emerging role of epigenetics in the actions of alcohol. Alcohol Clin Exp Res. 2008; 32: 1525-34.
65. Nottrott S, Simard MJ, Richter JD. Human let-7a miRNA blocks protein production on actively translating polyribosomes. Nat Struct Mol Biol. 2006; 13: 1108-14.
66. Humphreys DT, Westman BJ, Martin DI, et al. MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function. Proc Natl Acad Sci USA. 2005; 102: 16961-6.
67. Liu J, Valencia-Sanchez MA, Hannon GJ, et al. MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies. Nat Cell Biol. 2005; 7: 719-23.
68. Whittaker R, Loy PA, Sisman E, et al. Identification of MicroRNAs that control lipid droplet formation and growth in hepatocytes via high-content screening. J Biomol Screen. 2010; 15: 798-805.
69. O'Connell RM, Taganov KD, Boldin MP, et al. MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci USA. 2007; 104: 1604-9.
70. Perry MM, Moschos SA, Williams AE, et al. Rapid changes in microRNA-146a expression negatively regulate the IL-1beta-induced inflammatory response in human lung alveolar epithelial cells. J Immunol. 2008; 180: 5689-98.
71. Mandrekar P, Bala S, Catalano D, et al. The opposite effects of acute and chronic alcohol on lipopolysaccharide-induced inflammation are linked to IRAK-M in human monocytes. J Immunol. 2009; 183: 1320-7.
72. Rai D, Karanti S, Jung I, et al. Coordinated expression of microRNA-155 and predicted target genes in diffuse large B-cell lymphoma. Cancer Genet Cytogenet. 2008; 181: 8-15.
73. Fuseler JW, Merrill DM, Rogers JA, et al. Analysis and quantitation of NF-kappaB nuclear translocation in tumor necrosis factor alpha (TNF-alpha) activated vascular endothelial cells. Microsc Microanal. 2006; 12: 269-76.
74. Tang Y, Banan A, Forsyth CB, et al. Effect of alcohol on miR-212 expression in intestinal epithelial cells and its potential role in alcoholic liver disease. Alcohol Clin Exp Res. 2008; 32: 355-64.
75. Wang Y, Yao HL, Cui CB, et al. Paracrine signals from mesenchymal cell populations govern the expansion and differentiation of human hepatic stem cells to adult liver fates. Hepatology. 2010; 52: 1443-54.
76. Scholten D, Osterreicher CH, Scholten A, et al. Genetic labeling does not detect epithelial-to-mesenchymal transition of cholangiocytes in liver fibrosis in mice. Gastroenterology. 2010; 139: 987-98.
77. Pintilie DG, Shupe TD, Oh SH, et al. Hepatic stellate cells' involvement in progenitor-mediated liver regeneration. Lab Invest. 2010; 90: 1199-208.
78. Jung Y, Brown KD, Witek RP, et al. Accumulation of hedgehog-responsive progenitors parallels alcoholic liver disease severity in mice and humans. Gastroenterology. 2008; 134: 1532-43.
79. Roskams T, Desmet V. Ductular reaction and its diagnostic significance. Semin Diagn Pathol. 1998; 15: 259-69.
80. Roskams T, Yang SQ, Koteish A, et al. Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease. Am J Pathol. 2003; 163: 1301-11.
81. Lynn FC. Meta-regulation: microRNA regulation of glucose and lipid metabolism. Trends Endocrinol Metab. 2009; 20: 452-9.
82. Girard M, Jacquemin E, Munnich A, et al. miR-122, a paradigm for the role of microRNAs in the liver. J Hepatol. 2008; 48: 648-56.
83. Raver-Shapira N, Marciano E, Meiri E, et al. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell. 2007; 26: 731-43.
84. Cheung O, Puri P, Eicken C, et al. Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression. Hepatology. 2008; 48: 1810-20.
85. Li S, Chen X, Zhang H, et al. Differential expression of microRNAs in mouse liver under aberrant energy metabolic status. J Lipid Res. 2009; 50: 1756-65.
86. Bala S, Petrasek J, Mundkur S, et al. Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases. Hepatology. 2012; 56: 1946-57.
87. Min HK, Kapoor A, Fuchs M, et al. Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease. Cell Metab. 2012; 15: 665-74.
88. Lee J, Padhye A, Sharma A, et al. A pathway involving farnesoid X receptor and small heterodimer partner positively regulates hepatic sirtuin 1 levels via microRNA-34a inhibition. J Biol Chem. 2010; 285: 12604-11.
89. He W, Wang Y, Zhang MZ, et al. Sirt1 activation protects the mouse renal medulla from oxidative injury. J Clin Invest. 2010; 120: 1056-68.
90. Shen Z, Liang X, Rogers CQ, et al. Involvement of adiponectin-SIRT1-AMPK signaling in the protective action of rosiglitazone against alcoholic fatty liver in mice. Am J Physiol Gastrointest Liver Physiol. 2010; 298: G364-74.
91. Yin H, Hu M, Zhang R, et al. MicroRNA-217 promotes ethanol-induced fat accumulation in hepatocytes by down-regulating SIRT1. J Biol Chem. 2012; 287: 9817-26.
92. Li Z, Chen L, Kabra N, et al. Inhibition of SUV39H1 methyltransferase activity by DBC1. J Biol Chem. 2009; 284: 10361-6.
93. Yamakuchi M, Ferlito M, Lowenstein CJ. miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci USA. 2008; 105: 13421-6.
94. Lewis BP, Shih IH, Jones-Rhoades MW, et al. Prediction of mammalian microRNA targets. Cell. 2003; 115: 787-98.
95. Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA. 2008; 105: 10513-8.
96. Starkey Lewis PJ, Dear J, Platt V, et al. Circulating microRNAs as potential markers of human drug-induced liver injury. Hepatology. 2011; 54: 1767-76.
97. Zhang Y, Jia Y, Zheng R, et al. Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases. Clin Chem. 2010; 56: 1830-8.
98. Ladeiro Y, Couchy G, Balabaud C, et al. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology. 2008; 47: 1955-63.
99. Yeligar S, Tsukamoto H, Kalra VK. Ethanol-induced expression of ET-1 and ET-BR in liver sinusoidal endothelial cells and human endothelial cells involves hypoxia-inducible factor-1alpha and microrNA-199. J Immunol. 2009; 183: 5232-43.
100. Dolganiuc A, Petrasek J, Kodys K, et al. MicroRNA expression profile in Lieber-DeCarli diet-induced alcoholic and methionine choline deficient diet-induced nonalcoholic steatohepatitis models in mice. Alcohol Clin Exp Res. 2009; 33: 1704-10.
101. Avissar M, McClean MD, Kelsey KT, et al. MicroRNA expression in head and neck cancer associates with alcohol consumption and survival. Carcinogenesis. 2009; 30: 2059-63.
102. Dippold RP, Vadigepalli R, Gonye GE, et al. Chronic ethanol feeding enhances miR-21 induction during liver regeneration while inhibiting proliferation in rats. Am J Physiol Gastrointest Liver Physiol. 2012; 303: G733-43.
103. Dippold RP, Vadigepalli R, Gonye GE, et al. Chronic ethanol feeding alters miRNA expression dynamics during liver regeneration. Alcohol Clin Exp Res. 2013; 37(Suppl. 1): E59-69.
104. Liu J, Carmell MA, Rivas FV, et al. Argonaute2 is the catalytic engine of mammalian RNAi. Science. 2004; 305: 1437-41.
105. Hutvagner G, Zamore PD. A microRNA in a multiple-turnover RNAi enzyme complex. Science. 2002; 297: 2056-60.
106. Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet. 2008; 9: 102-14.